Jasper Therapeutics Is A Clinical Stage Biotechnology Company Based In Redwood Citycaliforniafounded In 2019The Company Focuses On Developing Innovative Therapies For Mast Cell Driven Diseases And Enhancing Stem Cell Transplant Conditioning Regimenswith A Team Of Approximately 64 Employeesjasper Operates In Two Main Therapeutic Areasmast Cell Diseases And Hematopoietic Stem Cell Transplantation One Of Jasper S Key Products Is Briquilimaba Monoclonal Antibody Designed To Target The C Kitcd117Receptorthis Therapy Aims To Deplete Mast Cells And Diseased Stem Cellswith Ongoing Clinical Applications For Chronic Spontaneous Urticariachronic Inducible Urticariaasthmaand Severe Combined Immunodeficiencyscidpatients Requiring Second Transplantsthe Company Has Demonstrated The Safety And Efficacy Of Briquilimab In Over 160 Subjects During Its Clinical Trialsjasper Is Committed To Advancing Its Therapies To Improve Patient Outcomes In These Critical Areas
